ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1,4,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
2,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
3,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
4,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
5,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
6,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
7,1,Arthritis reactive,Spondyloarthropathies,Joint disorders,Musc,N
7,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
8,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
8,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
9,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
10,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
12,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
12,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
12,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
13,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
14,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
15,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
16,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
17,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
18,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
19,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
20,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
20,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
20,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
20,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
22,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
22,2,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
23,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
24,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
24,3,Headache,Headaches NEC,Headaches,Nerv,N
24,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
24,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
24,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
24,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
25,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
26,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
27,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
27,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
29,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
30,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
32,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
32,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
33,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
34,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
34,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
35,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
36,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
36,2,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
36,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
37,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
37,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
37,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
37,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
37,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
37,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
38,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
39,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
39,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
39,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
39,4,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
40,1,Hyperphosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
40,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
40,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
40,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
40,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
41,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
42,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
42,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
43,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
44,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
44,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
44,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
45,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
46,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
47,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
48,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
49,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
50,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
51,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
51,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
51,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
51,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
52,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
53,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
54,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
55,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
56,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
57,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
58,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
58,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
60,1,Deafness,Hearing losses,Hearing disorders,Ear,N
60,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
61,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
62,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
62,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
62,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
63,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
64,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
65,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
65,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
65,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
65,4,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
66,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
67,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
68,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
69,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
69,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
70,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
71,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
71,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
72,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
72,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
73,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
74,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
74,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
75,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
75,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
76,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
77,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
77,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
79,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
79,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
80,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
81,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
82,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
83,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
83,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
84,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Deafness,Hearing losses,Hearing disorders,Ear,N
85,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
86,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
87,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
88,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
88,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
90,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
91,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
91,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
91,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
91,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
91,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
92,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
92,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
93,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
94,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
95,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
96,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
96,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
97,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
98,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
99,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
99,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
99,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
100,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
100,2,Sweat discolouration,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
101,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
102,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
104,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
105,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
105,2,Periorbital infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
106,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
106,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
107,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
108,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
109,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
110,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
111,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
112,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
112,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
112,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
113,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
114,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
114,2,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
115,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
115,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
116,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
117,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
118,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
119,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
119,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
120,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
121,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
122,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
123,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
123,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
123,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
124,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
125,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
125,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
126,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
127,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
128,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
129,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
130,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
131,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
132,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
133,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
133,2,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
133,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
133,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
134,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
135,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
136,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
137,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
138,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
139,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
140,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
140,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
140,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
141,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
141,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
142,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
143,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
143,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
144,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
145,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
146,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
147,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
148,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
149,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
150,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
151,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
152,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
153,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
154,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
155,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
156,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
157,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
157,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
157,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
158,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
159,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
160,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
161,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
161,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
162,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
162,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
162,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
162,4,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
162,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
162,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
163,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
163,2,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
163,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
164,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
164,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
164,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
164,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
164,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
165,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
166,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
166,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
166,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
167,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
168,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
168,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
169,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
169,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
170,1,Cardiac pacemaker insertion,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
171,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
172,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
173,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
173,2,Small cell lung cancer metastatic,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
174,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
174,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
174,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
174,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
175,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
176,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
177,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
178,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
178,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
178,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
179,1,Human chorionic gonadotropin increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
180,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
181,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
181,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
182,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
183,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
184,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
185,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
186,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
187,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
187,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
188,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
189,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
189,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
190,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
191,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
192,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
193,1,Deafness,Hearing losses,Hearing disorders,Ear,N
194,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
195,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
196,1,T-cell chronic lymphocytic leukaemia,Leukaemias chronic T-cell,Leukaemias,Neopl,Y
197,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
198,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
199,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
199,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
199,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
200,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
201,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
201,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
201,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
201,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
201,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
202,1,Alveolar soft part sarcoma metastatic,Alveolar soft part sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
202,2,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
203,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
203,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
203,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
203,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
203,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
203,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
203,7,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
204,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
204,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
205,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
206,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
206,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
206,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
206,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
207,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
208,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
209,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
209,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
210,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
210,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
211,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
212,1,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
212,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
213,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
213,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
213,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
214,1,Invasive breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
215,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
216,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
217,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
217,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
218,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
219,1,Chondrocalcinosis,Crystal arthropathic disorders,Joint disorders,Musc,N
220,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
220,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
221,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
221,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
222,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
222,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
223,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
223,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
223,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
223,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
223,5,Ventricular failure,Heart failures NEC,Heart failures,Card,N
224,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
224,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
225,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
225,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
225,3,Sputum increased,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
226,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
227,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
228,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
228,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
228,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
228,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
228,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
229,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
230,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
231,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
232,1,Chronic lymphocytic leukaemia refractory,Leukaemias chronic lymphocytic,Leukaemias,Neopl,Y
232,2,Tumour flare,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
233,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
234,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
234,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
234,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
234,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
235,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
236,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
236,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
237,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
238,1,Gallbladder cancer metastatic,Gallbladder neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
239,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
239,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
239,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
240,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
240,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
240,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
241,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
242,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
243,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
244,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
244,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
244,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
244,4,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
244,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
244,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
244,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
244,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
244,9,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
244,10,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
244,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
245,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
245,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
246,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
247,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
247,2,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
248,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
248,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
249,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
249,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
250,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
251,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
252,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
253,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
254,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
254,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
255,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
255,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
255,3,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
255,4,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
256,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
256,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
256,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
256,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
256,5,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
256,6,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
256,7,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
256,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
256,9,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
256,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
256,11,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
256,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
256,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
256,14,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
257,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
258,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
259,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
260,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
261,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
262,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
263,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
263,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
263,3,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
263,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
263,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
263,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
263,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
263,8,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
263,9,Metastases to spleen,Metastases to specified sites,Metastases,Neopl,N
263,10,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,Y
263,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
263,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
263,13,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
263,14,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
264,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
265,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,Y
265,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
265,3,Hypersensitivity vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
265,4,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
265,5,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
266,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
266,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
267,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
267,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
268,1,Chest injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
268,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
268,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
268,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
268,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
268,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
268,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,9,Spinal column injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
269,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
269,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
269,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
270,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
270,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
271,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
272,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
273,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
274,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
275,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
276,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
277,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
277,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
278,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
278,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
278,3,Primary mediastinal large B-cell lymphoma refractory,Primary mediastinal large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
278,4,Tumour flare,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
279,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
280,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
281,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
282,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
283,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
283,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
284,1,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
284,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
285,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
286,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
287,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
288,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
289,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
290,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
291,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
291,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
291,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
291,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
291,5,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
292,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
292,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
292,3,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
292,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
292,5,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
293,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
294,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
294,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
295,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
295,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
296,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
296,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
297,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
297,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
297,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
297,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
298,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
299,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
300,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
301,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
301,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
301,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,1,Glomerular filtration rate increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
302,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
303,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
304,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
305,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
306,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
307,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
308,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
309,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
310,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
311,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
312,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
313,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
314,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
315,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
316,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
317,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
318,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
319,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
320,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
320,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
320,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
320,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
320,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
321,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
322,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
323,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
323,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
323,3,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
324,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
325,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
326,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
326,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
326,3,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
327,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
327,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
327,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
327,4,Deafness,Hearing losses,Hearing disorders,Ear,N
327,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
328,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
329,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
329,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
330,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
331,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
331,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
332,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
333,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
334,1,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
335,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
336,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
337,1,Acute leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,Y
337,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
337,3,Myelodysplastic syndrome with excess blasts,Myelodysplastic syndromes,Leukaemias,Neopl,N
338,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
338,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
338,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
338,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
339,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
340,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
340,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
341,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
341,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
342,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
342,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
343,1,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
344,1,Gastrointestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
344,2,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
345,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
345,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
346,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
347,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
348,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
349,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
349,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
350,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
350,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
350,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
351,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
352,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
352,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
353,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
354,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
355,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
355,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
355,3,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
356,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
357,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
358,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
359,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
360,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
361,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
362,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
363,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
363,2,Fear of falling,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
363,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
363,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
364,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
364,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
365,1,Amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
365,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
366,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
367,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
367,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
368,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
368,2,Blood product transfusion dependent,Disability issues,Lifestyle issues,SocCi,N
368,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
369,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
369,2,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
369,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
369,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
370,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
371,1,Deafness,Hearing losses,Hearing disorders,Ear,N
371,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
372,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
372,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
373,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
374,1,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
375,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
376,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
376,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
376,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
376,4,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
376,5,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
376,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
376,7,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
376,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
377,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
378,1,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
378,2,Haemodialysis complication,Dialysis related complications,Procedural related injuries and complications NEC,Inj&P,N
379,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
380,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
381,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
382,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
383,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
384,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
386,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
386,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
386,3,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
386,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
386,5,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
386,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
387,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
387,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
388,1,Lung squamous cell carcinoma stage III,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
388,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
388,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
388,4,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
389,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
390,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
391,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
392,1,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
392,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
392,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
393,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
393,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
394,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
394,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
395,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
396,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
397,1,Infective exacerbation of bronchiectasis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
397,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
398,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
398,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
398,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
399,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
399,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
400,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
401,1,Primary amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
401,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
402,1,Sarcoma of skin,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
403,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
404,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
404,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
404,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
405,1,Sarcoma of skin,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
406,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
407,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
407,2,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
408,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
408,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
409,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
410,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
411,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
412,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
413,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
413,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
414,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
414,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
415,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
415,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
416,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
416,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
416,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
417,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
418,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
418,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
418,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
418,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
418,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
418,6,Pneumonia haemophilus,Haemophilus infections,Bacterial infectious disorders,Infec,N
419,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
419,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
419,3,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
420,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
420,2,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
420,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
420,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
420,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
421,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
422,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
423,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
423,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
424,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
424,2,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
424,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
424,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
424,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
425,1,Cervical spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
425,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
426,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
426,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
427,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
428,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
429,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
430,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
431,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
432,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
433,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
434,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
435,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
436,1,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
437,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
437,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
438,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
439,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
439,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
439,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
439,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
440,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
441,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
442,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
442,2,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
443,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
443,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
443,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
443,4,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
444,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
444,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
445,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
445,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
446,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
446,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
446,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
447,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
447,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,3,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
447,4,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
447,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
447,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
447,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
447,8,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
447,9,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
448,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
449,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
449,2,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
450,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
451,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
451,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
452,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
453,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
454,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
455,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
455,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
455,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
456,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
457,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
458,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
459,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
459,2,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
460,1,Pancreatic neoplasm,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
461,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
461,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
462,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
463,1,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
464,1,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
465,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
465,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
465,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
465,4,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
465,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
466,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
467,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
467,2,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
467,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
468,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
468,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
468,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
468,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
468,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
469,1,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
470,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
470,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
470,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
470,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
471,1,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
472,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
473,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
474,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
474,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
475,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
475,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
475,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
475,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
475,5,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
475,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
476,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
477,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
478,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
479,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
480,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
481,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
481,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
482,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
483,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
484,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
484,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
485,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
485,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
486,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
486,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
486,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
487,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
487,2,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
488,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
489,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
490,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
491,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
492,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
492,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
492,3,Pancreatic failure,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
493,1,Metastases to skin,Metastases to specified sites,Metastases,Neopl,Y
494,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
495,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
495,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
495,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
495,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
495,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
495,6,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
495,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
495,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
495,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
495,10,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
495,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
495,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
496,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
496,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
497,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
498,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
498,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
499,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
499,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
500,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
501,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
501,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
502,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
502,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
503,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
504,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
505,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
505,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
506,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
507,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,Y
508,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
508,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
508,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
508,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
509,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
510,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
510,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
510,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
510,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
510,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
510,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
510,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
510,8,Mucosal dryness,Mucosal findings abnormal,General system disorders NEC,Genrl,N
510,9,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
510,10,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
510,11,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
510,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
510,13,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
510,14,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
510,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
510,16,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
510,17,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
510,18,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
511,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
511,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
511,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
512,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
512,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
512,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
513,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
514,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
514,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
514,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
514,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
515,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
515,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
515,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
515,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
516,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
516,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
516,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
516,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
516,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
516,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
516,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
516,8,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
516,9,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
516,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
517,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
517,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
517,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
517,4,Thyroiditis acute,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
518,1,Focal dyscognitive seizures,Partial complex seizures,Seizures (incl subtypes),Nerv,N
518,2,Focal dyscognitive seizures,Partial complex seizures,Seizures (incl subtypes),Nerv,N
519,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
519,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
519,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
519,4,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
519,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
519,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
519,7,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
519,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
519,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
520,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
520,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
520,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
521,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
521,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
521,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
522,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
522,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
522,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
522,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
523,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
523,2,Thyroiditis acute,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
524,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
525,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
525,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
525,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
526,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
526,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
527,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
527,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
527,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
528,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
528,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
528,3,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
528,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
528,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
528,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
528,7,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
529,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
529,2,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,Y
530,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
530,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
530,3,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
530,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
530,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
531,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
532,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
532,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
532,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
532,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
533,1,Anaplastic large cell lymphoma T- and null-cell types recurrent,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
533,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
533,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
534,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
535,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
535,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
535,3,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
535,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
535,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
536,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
537,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
537,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
538,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
538,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
538,3,Metastases to skin,Metastases to specified sites,Metastases,Neopl,N
539,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
539,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
539,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
540,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
541,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
541,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
541,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
542,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
542,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
542,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
543,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
544,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
544,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
544,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
544,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
544,5,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
545,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
545,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
546,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
547,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
548,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
549,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
550,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
551,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
551,2,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
552,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
552,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
553,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
553,2,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
554,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
555,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
555,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
556,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
557,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
558,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
559,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
560,1,Migraine,Migraine headaches,Headaches,Nerv,N
561,1,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
562,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
563,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
564,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
564,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
564,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
564,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
565,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
566,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
566,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
567,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
567,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
568,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
569,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
569,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
570,1,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
571,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
572,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
572,2,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
572,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
572,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
572,5,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
572,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
573,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
573,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
573,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
574,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
574,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
574,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
575,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
576,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
577,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
577,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
577,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
577,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
578,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
579,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
579,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
580,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
581,1,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
582,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
582,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
583,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
583,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
583,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
583,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
583,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
583,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
584,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
585,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
586,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
586,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
586,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
587,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
587,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
588,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
588,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
589,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
589,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
589,3,Primary amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
589,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
589,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
590,1,Eosinophilic cellulitis,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
591,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
591,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
592,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
593,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
593,2,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
594,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
594,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
594,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
595,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
595,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
595,3,Groin infection,Infections NEC,Infections - pathogen unspecified,Infec,N
595,4,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
595,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
596,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
596,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
597,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
598,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
598,2,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
599,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
599,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
599,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
599,4,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
599,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
600,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
601,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
602,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
602,2,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
603,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
604,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
605,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
605,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
605,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
605,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
605,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
605,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
605,7,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
605,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
605,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
605,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
605,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
605,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
606,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
607,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
607,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
608,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
608,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
608,3,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
609,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
610,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
610,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
611,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,Y
612,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
613,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
614,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
615,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
616,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
617,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
618,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
618,2,Tumour flare,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
619,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
619,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
619,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
620,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
621,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
622,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
623,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
624,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
624,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
625,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
626,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
627,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
627,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
627,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
627,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
628,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
628,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
629,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
629,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
629,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
630,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
631,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
632,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
632,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
633,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
634,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
635,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
635,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
635,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
636,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
637,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
637,2,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
637,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
638,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
639,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
640,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
640,2,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
640,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
641,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
641,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
641,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
641,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
641,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
642,1,Influenza A virus test,Virus identification and serology,Microbiology and serology investigations,Inv,N
642,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
643,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
644,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
644,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
644,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
645,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
645,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
646,1,Capillaritis,Skin vasculitides,Skin vascular abnormalities,Skin,N
646,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
647,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
648,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
648,2,Lymphoplasmacytoid lymphoma/immunocytoma,Lymphoplasmacytoid lymphomas/immunocytomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
648,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
649,1,Essential tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
650,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
650,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
650,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
650,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
651,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
652,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
652,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
652,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
652,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
653,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
653,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
653,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
654,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
655,1,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
655,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
656,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
657,1,Mantle cell lymphoma refractory,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
658,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
658,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
658,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
658,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
658,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
659,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
660,1,Cutaneous lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
660,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
660,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
661,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
662,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
662,2,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
663,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
664,1,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
665,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
666,1,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
667,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
667,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
668,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
668,2,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
668,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
669,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
670,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
670,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
671,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
671,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
672,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
672,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
672,3,Splenic marginal zone lymphoma,Splenic marginal zone lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
672,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
673,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
673,2,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
673,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
674,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
674,2,Diffuse large B-cell lymphoma refractory,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
674,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
675,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
676,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
676,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
676,3,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
676,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
676,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
677,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
677,2,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
678,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
679,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
680,1,Angioimmunoblastic T-cell lymphoma,Angioimmunoblastic T-cell lymphomas,Lymphomas non-Hodgkin's T-cell,Neopl,Y
681,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
681,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
681,3,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
681,4,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
681,5,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
682,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
682,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
683,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
684,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
685,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
686,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
686,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
686,3,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
687,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
687,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
687,3,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
688,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
688,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
688,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
688,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
688,5,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
689,1,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
690,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
690,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
690,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
690,4,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
690,5,Immunoglobulins increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
690,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
690,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
691,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
691,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
692,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
692,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
693,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
693,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
694,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
695,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
696,1,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
697,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
698,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
699,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
700,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
701,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
701,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
702,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
703,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
703,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
703,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
703,4,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
703,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
703,6,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
703,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
703,8,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
704,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
704,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
704,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
704,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
704,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
705,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
705,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
705,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
705,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
705,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
706,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
707,1,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
707,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
708,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
708,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
709,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
709,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
709,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
709,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
709,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
709,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
709,7,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
709,8,External ear cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
709,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
709,10,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
709,11,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
709,12,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
709,13,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
710,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
711,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
711,2,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
711,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
711,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
711,5,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
711,6,Diverticulum intestinal haemorrhagic,Diverticula,Diverticular disorders,Gastr,N
711,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
711,8,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
711,9,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
711,10,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
712,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
712,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
712,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
713,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
713,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
713,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
713,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
714,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
715,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
715,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
715,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
716,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
717,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
717,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
717,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
717,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
717,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
717,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
718,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
719,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
720,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
720,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
721,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
722,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
722,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
722,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
722,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
722,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
723,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
723,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
724,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
724,2,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
724,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
725,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
726,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
727,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
728,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
729,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
729,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
730,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
730,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
730,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
731,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
731,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
731,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
732,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
732,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
733,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
733,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
733,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
733,4,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
734,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
734,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
735,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
735,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
736,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
736,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
736,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
736,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
737,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
737,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
737,3,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
738,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
739,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
739,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
739,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
740,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
741,1,High grade B-cell lymphoma Burkitt-like lymphoma refractory,High grade B-cell lymphomas Burkitt-like lymphoma,Lymphomas non-Hodgkin's B-cell,Neopl,Y
742,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
743,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
744,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
744,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
744,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
745,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
745,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
746,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
746,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
746,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
746,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
746,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
747,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
748,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
748,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
749,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
749,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
749,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
750,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
751,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
751,2,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
752,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
752,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
752,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
752,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
752,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
752,6,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
753,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
754,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
755,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
755,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
755,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
755,4,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
756,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
756,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
756,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
756,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
756,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
756,6,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
757,1,Diffuse large B-cell lymphoma refractory,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
758,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
758,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
759,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
759,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
759,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
759,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
759,5,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
759,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
760,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
760,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
761,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
761,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
762,1,Otitis media bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
762,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
762,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
762,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
762,5,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
763,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
763,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
764,1,Leiomyosarcoma recurrent,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
764,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
765,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
765,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
765,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
766,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
766,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
767,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
767,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
768,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
768,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
768,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
768,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
768,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
768,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
769,1,Primary mediastinal large B-cell lymphoma,Primary mediastinal large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
770,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
771,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
771,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
771,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
771,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
772,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
772,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
772,3,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
773,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
773,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
773,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
774,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
775,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
776,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
777,1,Myelodysplastic syndrome with multilineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,N
777,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
778,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
778,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
778,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
778,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
778,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
778,6,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
778,7,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
779,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
780,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
780,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
780,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
780,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
781,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
782,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
782,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
782,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
782,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
782,5,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
783,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
783,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
784,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
784,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
785,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
785,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
786,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
786,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
787,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
787,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
787,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
787,4,Sternal fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
788,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
789,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
789,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
789,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
789,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
789,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
789,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
790,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
790,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
791,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
792,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
792,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
792,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
793,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
794,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
795,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
796,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
797,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
797,2,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
798,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
799,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
800,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
800,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
800,3,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
801,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
801,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
802,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
802,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
802,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
802,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
802,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
802,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
803,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
804,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
805,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
805,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
805,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
805,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
805,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
806,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
807,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
807,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
808,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
809,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
809,2,Biliary tract infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,Y
809,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
810,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
811,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
812,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
812,2,Hypertensive heart disease,Cardiac hypertensive complications,"Cardiac disorders, signs and symptoms NEC",Card,N
812,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
812,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
812,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
813,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
814,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
815,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
816,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
817,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
817,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
817,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
817,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
818,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
819,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
820,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
821,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
822,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
822,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
822,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
822,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
822,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
822,6,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
823,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
823,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
824,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
825,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
826,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
827,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
828,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
828,2,Gastrointestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
828,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
828,4,Jugular vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
828,5,Necrosis ischaemic,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
828,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
829,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
829,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
830,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
831,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
831,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
832,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
832,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
833,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
834,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
834,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
835,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
836,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
836,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
836,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
837,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
837,2,Diffuse large B-cell lymphoma refractory,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
838,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
838,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
839,1,Colon cancer stage III,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
840,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
841,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
841,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
842,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
842,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
843,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
843,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
843,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
844,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
844,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
844,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
844,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
844,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
844,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
844,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
845,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
845,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
846,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
847,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
848,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
849,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
849,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
849,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
849,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
850,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
850,2,Superior vena cava occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
851,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
852,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
852,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
853,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
854,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
855,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
856,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
856,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
857,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
858,1,Amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
858,2,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,Y
859,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
860,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
861,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
862,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
863,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
864,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
865,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
865,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
866,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
867,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
868,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
868,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
869,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
870,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
871,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
872,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
873,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
874,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
875,1,Diffuse large B-cell lymphoma refractory,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
876,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
876,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
877,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
877,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
877,3,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
877,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
877,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
878,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
878,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
879,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
880,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
881,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
881,2,Male sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
882,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
883,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
883,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
883,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
883,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
883,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
883,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
883,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
884,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
884,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
884,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
884,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
885,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
886,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
886,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
886,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
887,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
887,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
887,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
887,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
888,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
888,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
889,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
889,2,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
890,1,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
891,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
891,2,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
891,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
891,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
892,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
893,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
893,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
894,1,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
894,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
895,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
896,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
896,2,Pre-existing disease,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
897,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
897,2,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
898,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
898,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
899,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
899,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
899,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
899,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
899,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
899,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
900,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
900,2,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
901,1,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
902,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
903,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
904,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
905,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
905,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
905,3,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
905,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
906,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
906,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
906,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
906,4,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
906,5,Spinal cord disorder,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
907,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
907,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
908,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
908,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
909,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
909,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
909,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
909,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
910,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
911,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
911,2,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
912,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
913,1,Diffuse large B-cell lymphoma refractory,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
914,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
915,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
915,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
915,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
915,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
915,5,Nail bed infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
915,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
915,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
915,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
915,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
916,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
917,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
917,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
917,3,Mucocutaneous rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
917,4,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
917,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
917,6,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
917,7,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
918,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
919,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
920,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
921,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
922,1,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
923,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
923,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
923,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
923,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
923,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
923,6,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
923,7,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,Y
923,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
924,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
924,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
925,1,Diffuse large B-cell lymphoma refractory,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
925,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
926,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
926,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
927,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
928,1,Adenocarcinoma gastric,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
928,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
928,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
929,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
930,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
931,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
931,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
932,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
932,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
932,3,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
933,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
934,1,Angioimmunoblastic T-cell lymphoma,Angioimmunoblastic T-cell lymphomas,Lymphomas non-Hodgkin's T-cell,Neopl,Y
935,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
936,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
937,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
938,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
939,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
939,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
940,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
940,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
940,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
940,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
940,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
941,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
941,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
942,1,Transformation to acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
943,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
943,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
944,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
944,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
945,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
946,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
946,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
946,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
947,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
948,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
948,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
949,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
949,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
949,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
949,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
950,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
950,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
950,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
951,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
951,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
952,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
952,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
952,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
952,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
953,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
954,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
955,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
955,2,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
955,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
955,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
955,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
955,6,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
955,7,Radius fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
956,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
957,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
958,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
959,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
959,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
959,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
959,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
960,1,Diffuse large B-cell lymphoma refractory,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
961,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
962,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
962,2,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
963,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
964,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
965,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
966,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
966,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
966,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
966,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
967,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
968,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
968,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
969,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
969,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
969,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
970,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
970,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
970,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
970,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
970,5,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
971,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
971,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
972,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
973,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
974,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
975,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
976,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
977,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
978,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
979,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
980,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
980,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
980,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
980,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
980,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
980,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
980,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
980,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
981,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
982,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
983,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
983,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
984,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
985,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
986,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
986,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
987,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
987,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
988,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
989,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
990,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
991,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
991,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
991,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
992,1,Diffuse large B-cell lymphoma refractory,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
993,1,Histiocytic sarcoma,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
994,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
994,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
994,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
995,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
996,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
997,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
998,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
999,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1000,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1001,1,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
1002,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1003,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1004,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1005,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
1005,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1005,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1005,4,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1005,5,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1006,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1006,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1006,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1007,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1008,1,Mantle cell lymphoma stage IV,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1009,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1010,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1010,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1010,3,Peripheral T-cell lymphoma unspecified refractory,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
1010,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1011,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1011,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1012,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1013,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1014,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1015,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
1015,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1015,3,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1016,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1016,2,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1017,1,Adult T-cell lymphoma/leukaemia,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
1018,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1019,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1020,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1021,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1022,1,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1023,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1024,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1025,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1025,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1026,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1026,2,Fractured sacrum,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1026,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1026,4,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1027,1,Exposed bone in jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1027,2,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1027,3,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1028,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1029,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1030,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1031,1,Exposed bone in jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1031,2,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1031,3,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1032,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1033,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1033,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1033,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1033,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1034,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1035,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1036,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1037,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1038,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1038,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1039,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1040,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1041,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1041,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1041,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1041,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1041,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1041,6,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1042,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1043,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1043,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1044,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1045,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1045,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1045,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1045,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1046,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1047,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1048,1,Actinomycosis,Actinomycotic infectious disorders,Bacterial infectious disorders,Infec,N
1048,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1048,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1048,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1049,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1050,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1051,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1051,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1051,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1052,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1053,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1054,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1054,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1054,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1055,1,Tumour rupture,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1056,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1056,2,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1056,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1057,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1057,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1057,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1057,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1057,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1057,6,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1057,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1058,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1058,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1059,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1059,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1060,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1061,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1061,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1062,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1062,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1062,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1062,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1063,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1063,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1064,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1064,2,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1064,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1065,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1065,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1066,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1066,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1066,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1066,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1066,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1067,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1067,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1067,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1068,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1068,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1069,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1069,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1070,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1071,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1072,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1072,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1072,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1073,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1074,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1075,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1075,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1075,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1075,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
1075,5,Fungal test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
1075,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1075,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1075,8,Respirovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1076,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1077,1,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1077,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1078,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1079,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1080,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1080,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1081,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1081,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1082,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1083,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1084,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1084,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1084,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1085,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1086,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1086,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1086,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1087,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1087,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1088,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1088,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1088,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1089,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1089,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1089,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1090,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1090,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1090,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1091,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1091,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1091,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1092,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1093,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1094,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1094,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1094,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1094,4,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1094,5,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1094,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1095,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1095,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1096,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1097,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1097,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1097,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1098,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1098,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1099,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1099,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1100,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1100,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1101,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1102,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1102,2,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1103,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1103,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1104,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1104,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1105,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1105,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1106,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1106,2,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1107,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1108,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1108,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1109,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1109,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1110,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1111,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1112,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1113,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1114,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1114,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1115,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1115,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1116,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1117,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1118,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1119,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1119,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1119,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1120,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1121,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1121,2,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1121,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1122,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1123,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1123,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1123,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1123,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1123,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1123,6,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1123,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1123,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1124,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1124,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1124,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1124,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1125,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1125,2,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1125,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1125,4,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1125,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1125,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1125,7,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1125,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1125,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1125,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1125,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1126,1,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1127,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1127,2,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1127,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1127,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1127,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1128,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1128,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1128,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1129,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1129,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1129,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1130,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1131,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1132,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1132,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1132,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1133,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1134,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1134,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1134,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1134,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1134,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1135,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1136,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1137,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1137,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1138,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1138,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1138,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1139,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1139,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1139,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1139,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1139,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1139,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1140,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1141,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1141,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1141,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1141,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1142,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1143,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1143,2,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1143,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1144,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1145,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1146,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1146,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1146,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1146,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1146,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1146,6,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1147,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1147,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1148,1,Laryngeal squamous cell carcinoma,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
1148,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1149,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1149,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1150,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1151,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1151,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1152,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1153,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1153,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1153,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1153,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1153,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1153,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1153,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1154,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1154,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1154,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1155,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1155,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1156,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1156,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1157,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1158,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1158,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1158,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1159,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1160,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1161,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1162,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1163,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1163,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1164,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1165,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1165,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1166,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1167,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1167,2,Visceral leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
1168,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1168,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1168,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1168,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1168,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1168,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1168,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1169,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1169,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1170,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1170,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1170,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1171,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1171,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1171,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1171,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1172,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1173,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1174,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1174,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1175,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1176,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1176,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1176,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1177,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1178,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1179,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1179,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1180,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1181,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1181,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1181,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1181,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1181,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1181,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1182,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1183,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1184,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1184,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1185,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1185,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1186,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1187,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1187,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1187,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1187,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1188,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1188,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1189,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1190,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1190,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1190,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1190,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1190,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1190,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1191,1,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1192,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1193,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1193,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1193,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1193,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1193,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1193,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1193,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1193,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1193,9,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1193,10,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1193,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1193,12,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1193,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1193,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1193,15,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1193,16,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1193,17,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1194,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1194,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1195,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1196,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1197,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1198,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1199,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1199,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1199,3,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1199,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1200,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1201,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1201,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1201,3,Dissociative identity disorder,Dissociative states,Dissociative disorders,Psych,N
1201,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1201,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1201,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1201,7,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1201,8,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1202,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1202,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1202,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1202,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1202,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1202,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1202,7,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1203,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1203,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1203,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1203,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1203,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1203,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1204,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1205,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1205,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1206,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1207,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1207,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1207,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1208,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1208,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1208,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1208,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1208,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1208,6,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1208,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1208,8,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1208,9,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1208,10,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1208,11,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1209,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1210,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1210,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1210,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1211,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1211,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1212,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1212,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1212,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1212,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1212,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1213,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1214,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1215,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1215,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1215,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1216,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1217,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1218,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1218,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1218,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1218,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1218,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1218,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1218,7,Food aversion,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1218,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1218,9,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1218,10,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1218,11,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1218,12,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1218,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1218,14,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1218,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1218,16,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
1218,17,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1218,18,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1219,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1219,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1219,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1219,4,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1219,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1219,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1220,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1220,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1220,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1220,4,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
1220,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1220,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1221,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1221,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1222,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1222,2,Chillblains,Conditions caused by cold,Injuries by physical agents,Inj&P,N
1222,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1222,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1222,5,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1222,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1222,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1222,8,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1222,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1222,10,Vertebral lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1223,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1223,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1224,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1224,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1224,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1224,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1224,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1224,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1224,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1224,8,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1225,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1226,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1226,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1227,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1228,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1228,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1229,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1230,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1230,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1230,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1230,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1230,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1230,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1230,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1231,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1231,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1231,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1231,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1231,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1232,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1232,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1233,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1233,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1234,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1235,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1236,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1237,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1237,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1238,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1239,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1240,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1241,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1242,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1243,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1244,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1245,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1245,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1245,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1246,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1247,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1247,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1247,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1248,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1249,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1250,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1251,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1251,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1251,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1251,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1251,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1252,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1252,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1253,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1254,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1255,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1256,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1256,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1256,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1256,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1256,5,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1256,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1256,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1256,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1256,9,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1256,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1256,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1256,12,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1257,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1257,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1257,3,Thyroiditis acute,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1258,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1259,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1259,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1259,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1260,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1261,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1262,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1263,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1263,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1263,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1264,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1264,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1265,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1265,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1266,1,Dystonic tremor,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1267,1,Marginal zone lymphoma recurrent,Marginal zone lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1268,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1269,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1270,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1271,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1272,1,Pregnancy test false positive,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1273,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1273,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1273,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1273,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1274,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1275,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1275,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1275,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1276,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1276,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1277,1,Plasmablastic lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1278,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1279,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1279,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1280,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1280,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1280,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1280,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1280,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1281,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1282,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1282,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1283,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1283,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
1283,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1284,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1285,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1286,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1287,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1288,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1289,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1290,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1290,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1290,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1290,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1290,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1291,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1291,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1291,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1291,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1291,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1291,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1292,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1292,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1292,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1292,4,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1292,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1292,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1293,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1294,1,Adult T-cell lymphoma/leukaemia,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
1295,1,Pericarditis constrictive,Noninfectious pericarditis,Pericardial disorders,Card,N
1296,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1297,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1297,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1298,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1299,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1299,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1299,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1300,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1300,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1301,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1302,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1303,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1304,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1305,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1306,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1307,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1308,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1309,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1309,2,Headache,Headaches NEC,Headaches,Nerv,N
1309,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1310,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1311,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1311,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1311,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1311,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1312,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1312,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1313,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1313,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1313,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1314,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1315,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1316,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1317,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1318,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1318,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1319,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1320,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1320,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1320,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1320,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1321,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1322,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1322,2,Vein rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1323,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1324,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1325,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1325,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1326,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1327,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1327,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1327,3,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1327,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1327,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1327,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1327,7,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1327,8,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1327,9,Varicophlebitis,Varicose veins NEC,Venous varices,Vasc,N
1328,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1328,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1328,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1328,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1328,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1328,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1328,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1328,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1329,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1330,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1330,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1331,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1331,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1331,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1332,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1333,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1333,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1333,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1334,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1334,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1334,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1335,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1336,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1337,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1337,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1337,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1337,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1337,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1337,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1337,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1338,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1338,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1339,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1340,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1340,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1340,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1340,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1340,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1341,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1341,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1342,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1343,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1344,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1345,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1346,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1347,1,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1348,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1348,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1350,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1350,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1350,3,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1350,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1351,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1351,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1352,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1353,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1353,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1354,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1354,2,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1354,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1354,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1354,5,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1355,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1356,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1357,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1358,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1358,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1358,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1358,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1358,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1358,6,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
1358,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1359,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1360,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1361,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1361,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1362,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1362,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1363,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1363,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1363,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1363,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1363,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1364,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1364,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1365,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1366,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1367,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1367,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1367,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1368,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1369,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1370,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1371,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1372,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1373,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1374,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1375,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1376,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1377,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1378,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1378,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1378,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1378,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1379,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1380,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1381,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1381,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1381,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1381,4,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1381,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1382,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1383,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1384,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1385,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1385,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1385,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1386,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1386,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1386,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1386,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1386,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1386,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1386,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1386,8,Myopathy,Myopathies,Muscle disorders,Musc,N
1386,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1387,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1387,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1388,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1388,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1389,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1389,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1390,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1390,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1390,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1391,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1392,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1393,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1394,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1395,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1395,2,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
1396,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1396,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1397,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1398,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1399,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1400,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1400,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1400,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1400,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1400,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1400,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1400,7,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1400,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1400,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1400,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1400,11,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1400,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1400,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1400,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1400,15,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1400,16,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1401,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1401,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1402,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1402,2,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1402,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1402,4,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1402,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1402,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1402,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1402,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1403,1,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1404,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1405,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1405,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1405,3,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1406,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1407,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1408,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1409,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1410,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1410,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1411,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1412,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1412,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1412,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1412,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1412,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1413,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1414,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1415,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1416,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1417,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1418,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1418,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1418,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1418,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1418,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1419,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1419,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1420,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1420,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1420,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1420,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1421,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1421,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1421,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1421,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1422,1,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1423,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1424,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1425,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1425,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1426,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1426,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1427,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1428,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1428,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1429,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1430,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1430,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1430,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1431,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1431,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1431,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1431,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1432,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1432,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1433,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1433,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1433,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1433,4,N-terminal prohormone brain natriuretic peptide decreased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1433,5,N-terminal prohormone brain natriuretic peptide increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1433,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1433,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1433,8,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1433,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1434,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1434,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1435,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1436,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1437,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1437,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1437,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1438,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1439,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1440,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1441,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1441,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1441,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1441,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1442,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1442,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1443,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1444,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1445,1,Angioimmunoblastic T-cell lymphoma recurrent,Angioimmunoblastic T-cell lymphomas,Lymphomas non-Hodgkin's T-cell,Neopl,N
1445,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1446,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1447,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1447,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1447,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1448,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1448,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1449,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1450,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1451,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1452,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1452,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1453,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1454,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1455,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1456,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1457,1,Androgenetic alopecia,Alopecias,Skin appendage conditions,Skin,N
1458,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1459,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1459,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1460,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1461,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1462,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1463,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1463,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1464,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1464,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1464,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1464,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1464,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1464,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1464,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1464,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1464,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1464,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1464,11,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1464,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1464,13,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1464,14,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1464,15,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1464,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1465,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1465,2,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1466,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1466,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1467,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1468,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1469,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1470,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1470,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1470,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1471,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1471,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1471,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1472,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1473,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1473,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1474,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1475,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1475,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1476,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1476,2,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
1477,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1478,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1478,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1479,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1480,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1481,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1482,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1482,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1483,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1483,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1484,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1484,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1485,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1486,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1487,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1487,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1488,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1489,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1490,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1490,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1490,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1491,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1492,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1493,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1493,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1494,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1495,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1495,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1495,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1495,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1495,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1495,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1496,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1497,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1498,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1498,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1499,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1499,2,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1499,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1499,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1500,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1500,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1501,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1501,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1501,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1501,4,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1502,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1502,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1502,3,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1503,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1503,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1504,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1504,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1504,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1505,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1506,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1506,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1507,1,Cerebral nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1507,2,Pulmonary nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1508,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1508,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1509,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1509,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1509,3,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1509,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1509,5,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1509,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1509,7,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1509,8,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1509,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1509,10,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1509,11,Vascular compression,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1510,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1511,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1511,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1512,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1513,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1514,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1515,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1516,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1516,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1516,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1516,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1517,1,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1518,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1518,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1519,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1520,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1520,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1521,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1521,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1521,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1522,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1523,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1524,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1525,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1526,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1527,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1527,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1527,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1527,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1527,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1528,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1529,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1530,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1531,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1531,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1532,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1532,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1532,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1533,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1534,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1534,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1535,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1536,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1536,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1537,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1537,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1538,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1538,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1538,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1538,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1538,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1539,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1540,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1540,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1541,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1541,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1541,3,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1541,4,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1541,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1541,6,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1541,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1541,8,Vascular compression,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1542,1,Exposure via body fluid,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1542,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1542,3,Pregnancy with contraceptive device,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1543,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1543,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1544,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1544,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1545,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1546,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1546,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1547,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1548,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1549,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1550,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1551,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1551,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1551,3,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1551,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1551,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1551,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1551,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1551,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1551,9,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1551,10,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1551,11,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1551,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1551,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1552,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1552,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1553,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1554,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1554,2,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1554,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1554,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1555,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1555,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1556,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1556,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1556,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1556,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1556,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1556,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1557,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1557,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1558,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1559,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1559,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1559,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1560,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1560,2,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1560,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1560,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1560,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1560,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1560,7,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1561,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1562,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1562,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1562,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1563,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1564,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1565,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1565,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1565,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1566,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1567,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1568,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1569,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1569,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1570,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
1571,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,N
1572,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1573,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1574,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1574,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1575,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1576,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1576,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1576,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1576,4,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1576,5,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1577,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1577,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1577,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1577,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1577,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1578,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1579,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1579,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1580,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1581,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1582,1,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1582,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1582,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1582,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1583,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1583,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1583,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1584,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1585,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1586,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1586,2,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1586,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1587,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1588,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1588,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1588,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1588,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1589,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1589,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1589,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1589,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1590,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1590,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1590,3,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1591,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1591,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1592,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1593,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1593,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1594,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1594,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1595,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1596,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1597,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1597,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1597,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1597,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1597,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1597,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1597,7,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1597,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1597,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1597,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1597,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1597,12,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1597,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1597,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1597,15,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1597,16,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1597,17,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1597,18,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1598,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1599,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1599,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1599,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1599,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1599,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1600,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1601,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1602,1,Pulmonary interstitial emphysema syndrome,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1603,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1604,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1605,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1606,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1607,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1607,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1607,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1608,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1609,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1609,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1609,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1609,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1609,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1609,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1609,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1610,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1611,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1612,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1612,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1613,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1614,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1614,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1615,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1616,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1617,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1617,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1617,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1617,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1617,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1617,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1617,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1618,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1619,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1619,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1619,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1619,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1619,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1620,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1621,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1621,2,Heart failure with preserved ejection fraction,Left ventricular failures,Heart failures,Card,N
1621,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1621,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1621,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1622,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1623,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1623,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1624,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1625,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1625,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1626,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1627,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1628,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1629,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1630,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1631,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1631,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1632,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1633,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1634,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1635,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1636,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1636,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1636,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1637,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1638,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1638,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1639,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1640,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1641,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1641,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1641,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1641,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1641,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1641,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1641,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1642,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1643,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1643,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1643,3,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1643,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1643,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1644,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1645,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1646,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1647,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1648,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1649,1,Light chain disease,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
1650,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1650,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1650,3,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1650,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1650,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1650,6,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1651,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1652,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1653,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1654,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1655,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1656,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1656,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1656,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1656,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1656,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1657,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1658,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1659,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1659,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1660,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1661,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1662,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1663,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1664,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1664,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1664,3,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1664,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1664,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1665,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1666,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1667,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1668,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1668,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1669,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1669,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1669,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1669,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1670,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1671,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1672,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1673,1,Primary hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1674,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1675,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1676,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1677,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1677,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1678,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1679,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1679,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1680,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1681,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1681,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1682,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1683,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1684,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1685,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1685,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1686,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1687,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1688,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1689,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1690,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1691,1,Aspiration bone marrow,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
1691,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1691,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1691,4,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1692,1,Headache,Headaches NEC,Headaches,Nerv,N
1692,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1693,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1693,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1693,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1693,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1693,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1694,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1694,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1694,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1694,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1695,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1696,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1696,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1696,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1697,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1698,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1699,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1700,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1701,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1702,1,Adjusted calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1702,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1703,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1704,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1705,1,Sickle cell anaemia with crisis,Sickle cell trait and disorders,Haemoglobinopathies,Blood,N
1706,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1707,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1708,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1709,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1710,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1711,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1712,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1713,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1713,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1714,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1715,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1716,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1716,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1717,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1718,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1718,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1718,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1718,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1718,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1718,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1718,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1718,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1718,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1718,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1719,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1720,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1720,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1721,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1722,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1723,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1724,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1724,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1724,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1724,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1725,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1726,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1727,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1727,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1727,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1727,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1728,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1729,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1729,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1730,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1730,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1731,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1732,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1733,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1733,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1733,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1734,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1734,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1735,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1736,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1737,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1738,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1739,1,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1740,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1741,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1742,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1743,1,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1743,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1743,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1744,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1745,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1746,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1746,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1746,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1747,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1748,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1749,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1750,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1751,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1752,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1752,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1752,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1752,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1753,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1754,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1755,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
1756,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1757,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1758,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1759,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1760,1,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1761,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1761,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1761,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1761,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1762,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1763,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1764,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1765,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1766,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1767,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1767,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1768,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1768,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1769,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1770,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1771,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1772,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1772,2,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
1772,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1772,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1773,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1774,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1775,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
1776,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1777,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1778,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1779,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1779,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1779,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1780,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1780,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1781,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1782,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1782,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1783,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1784,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1785,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1786,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1787,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1788,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1789,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1790,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1790,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1791,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1792,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1793,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1794,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1795,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1796,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1797,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1798,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1799,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
1800,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1801,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1801,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1802,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1803,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1803,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1804,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1805,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1806,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1807,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1808,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1809,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1810,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1811,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1812,1,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
